Navigation Links
HeartWare International, Inc. Announces Completion of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
Date:12/15/2010

eds from the notes offering for general corporate and working capital purposes, including, but not limited to, research and development, expansion of its manufacturing capabilities and/or licensing of or investment in complementary products, technologies or businesses.  HeartWare will not receive any of the proceeds from the common stock offering.

J.P. Morgan Securities LLC acted as the sole book-running manager for both the convertible notes and common stock offerings.  Canaccord Genuity Inc., Lazard Capital Markets LLC and Wells Fargo Securities, LLC acted as co-managers of the offerings.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state.  The issuer has filed a registration statement (including a prospectus) with the SEC for the offerings to which this communication relates.  Each offering of securities was made only by means of a prospectus and the related prospectus supplement.  You may get these documents for free by visiting EDGAR on the SEC Website at www.sec.gov.  Alternatively, copies of the prospectus and the related prospectus supplement can be obtained by contacting J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or by calling 1-866-803-9204.

About HeartWare International HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat patients suffering from advanced heart failure.  

Forward-Looking Statements This announcement contains forward-looking statements that are based on management's beliefs, assumptions and expectations and on information currently avai
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Presentation of HeartWare Clinical Results
2. HeartWare International Clinical Trial Shows 90% Survival at 180 Days
3. U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
4. HeartWare International Reports Third Quarter Revenues of $7.5 Million
5. HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City
6. HeartWare to Present at the UBS 2010 Global Life Sciences Conference
7. HeartWare to Present at Lazard Capital Markets Circulatory Assist Device Day
8. HeartWare to Report Financial Results for Third Quarter of 2010
9. HeartWare International Reports Third Quarter 2010 Revenues of $13.8 Million; Compared to $7.5 Million in Third Quarter of 2009
10. HeartWare Bridge-to-Transplant Data Featured as Late Breaking Clinical Trial at American Heart Association Scientific Sessions 2010
11. HeartWare to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)...   MedeAnalytics today unveils Revenue Integrity, ... visibility to a provider,s "mid-cycle" to optimize revenue ... Powered by the industry,s leading big data platform, ... between patient access and the business office where ... revenue capture, minimize audit risk and prepare providers ...
(Date:9/17/2014)... --  myMatrixx, a pharmacy and ancillary medical benefit manager for workers, ... has awarded myMatrixx with a "Best Places to Work ... row. Best Places to Work is ... Best Companies Group.  The competition, which involves months of ... insurance industry companies with at least 25 employees in ...
(Date:9/17/2014)... MADISON, Tenn. , Sept. 17, 2014 ... be; these infections are not only uncomfortable, they,re often ... best-laid social plans. pH-D Feminine Health Support ( http://ph-defense.com ... vaginal health. It is an all-natural, homeopathic product. ... the most common symptoms of vaginal infection. In many ...
Breaking Medicine Technology:MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3myMatrixx Honored with "Best Places to Work in Insurance" Award 2New Product from Vireo Systems: pH-D Feminine Health Support 2
... FRANCISCO, Calif., Aug. 25, 2011 Rigel Pharmaceuticals, Inc. ... M. Gower, chairman and chief executive officer, and Ryan ... Rigel, will present at two separate investor conferences in ... Healthcare Conference 2011Date: Thursday, September 8th at 10:20 a.m. ...
... Nutrastar International Inc. (OTCBB: NUIN; "Nutrastar" or the "Company"), ... Chinese Medicine ("TCM") consumer products, today announced that its ... under which Nutrastar may repurchase up to US$5 million ... 12 months. Under the program, the ...
Cached Medicine Technology:Nutrastar Announces Adoption of Share Repurchase Program 2Nutrastar Announces Adoption of Share Repurchase Program 3
(Date:9/18/2014)... Lake City, Utah (PRWEB) September 18, 2014 ... Now Spoonful of Comfort, an online food delivery service provider, ... , New Country Fresh Tomato Basil soup is a nod ... begins, of course, with a tangy tomato base, then Spoonful ... asiago and parmesan cheeses. A flashback to childhood has never ...
(Date:9/18/2014)... 2014 Computer Resources of America, Inc. ... New York City, has been awarded a contract to ... retailer with stores in over 150 countries. The services ... CRA being the retailer’s dispatch arm handling all IT ... Ramnarayan, Chief Executive Officer of CRA said, “We are ...
(Date:9/18/2014)... NY (PRWEB) September 18, 2014 ... which have special functions of adjusting human body ... have won great popularity with a variety of ... health food in China reached RMB187.4 billion, up ... 22.1% during 2006-2013. , View Full Report at ...
(Date:9/18/2014)... MA (PRWEB) September 18, 2014 ... its team and surgeon partners in Less Exposure ... joining SpineFrontier, Tamara authored an extensive education curriculum ... a Masters in Science in Organizational Leadership, and ... industries for eleven years. Bringing her to the ...
(Date:9/18/2014)... Dr. Suzaunna Clark, Psychologist, Life Coach and ... has to be seen to be believed and 2- ... to be used. Together, both lead to hearts that ... to do both. , Dr. Clark offers ... Hearts system, which provides professional guidance on dealing with ...
Breaking Medicine News(10 mins):Health News:An Old Classic Brings New Soup Delivery Options to Spoonful of Comfort 2Health News:CRA Awarded Managed Support Contract for Global Retailer 2Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 2Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 3Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 4Health News:SpineFrontier Inc. Makes Bold Move to Expand Its Internal Training Team to Collaborate With The LESSociety’s Less Exposure Surgery® University To Educate Surgeons. 2Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 2Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 3
... June 11 Orexigen(R) Therapeutics, Inc. (Nasdaq: ... of obesity, today announced the licensing of certain intellectual ... IP position underlying Contrave, its lead product candidate for ... agreement with GSK complements the IP foundation of Contrave, ...
... - Members of Congress Seek to Stem Growing Healthcare Coverage Shortfalls ... has introduced a bill, S. 1221, "The Medicare Prompt Pay ... introduced in the U.S. House of Representatives and currently has 45 ... Senators Arlen Specter (D-PA) and Pat Roberts (R-KS). The bill is ...
... WASHINGTON, June 11 A call for participants ... a national certification for medical interpreters. The National ... as an independent 501(c)3 non-profit certification entity, will ... ensure that the certification process is credible, transparent, ...
... Pharmaceuticals, Inc. (Nasdaq: TSPT ) announced today that ... company that it should expect to receive formal notice of ... new drug application (NDA) for Intermezzo (R) (zolpidem tartrate ... assigned a Prescription Drug User Fee Act (PDUFA) date of ...
... Help Grieving Children and Families , , CAMP HILL, ... 185 volunteers on Monday, June 15 at the Radisson Penn ... 6,500 hours - an average of nearly 35 hours each ... adolescents and their families at the Caring Place facility in ...
... Canada, June 11 Xenon today announced a strategic ... to discover and develop novel small molecule candidates for ... "We are very excited to be collaborating with Merck ... diseases," said Simon Pimstone, President and CEO of Xenon. ...
Cached Medicine News:Health News:Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R) 2Health News:Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R) 3Health News:Senate Bill to Protect Patients' Healthcare by Amending Medicare Coverage 2Health News:Senate Bill to Protect Patients' Healthcare by Amending Medicare Coverage 3Health News:Public Call for Participation on National Board of Certification for Medical Interpreters 2Health News:Public Call for Participation on National Board of Certification for Medical Interpreters 3Health News:Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo(R) 2Health News:Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo(R) 3Health News:Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo(R) 4Health News:Highmark Caring Place To Honor Midstate Volunteers 2Health News:Highmark Caring Place To Honor Midstate Volunteers 3Health News:Xenon Enters Cardiovascular Disease Collaboration With Merck & Co., Inc. 2
... The Leica TP1020 product family are ... a perfect combination of approved technology with ... processing and maximum safety for tissues at ... engineering design based on proven precision mechanics ...
The HMP300 Histo Pro delivers all the features and benefits that conventional tissue processing have to offer....
... electronic, motorized rotary microtomes ... applications of paraffin, semi-thin ... specimens in clinical, research, ... instruments display extra-ordinary ergonomic ...
... RM2235 is a robust rotary microtome ... biological specimens embedded in paraffin. The ... micrometer feed system ensures premium quality ... sectioning harder tissues. The RM2235 is ...
Medicine Products: